DanCann Pharma A/S (NGM:DANCAN)
Sweden · Delayed Price · Currency is SEK · Price in DKK 0.4440
-0.0080 (-1.77%)
At close: Dec 4, 2025
DanCann Pharma Revenue
DanCann Pharma had revenue of 1.62M DKK in the quarter ending September 30, 2025, a decrease of -12.78%. This brings the company's revenue in the last twelve months to 4.01M, down -49.97% year-over-year. In the year 2024, DanCann Pharma had annual revenue of 7.37M with 3.06% growth.
Revenue (ttm)
4.01M DKK
Revenue Growth
-49.97%
P/S Ratio
0.47
Revenue / Employee
802.20K DKK
Employees
5
Market Cap
2.81M SEK
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.37M | 219.00K | 3.06% |
| Dec 31, 2023 | 7.15M | -36.00K | -0.50% |
| Dec 31, 2022 | 7.19M | 4.88M | 211.89% |
| Dec 31, 2021 | 2.31M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AB Volvo | 493.79B |
| Telefonaktiebolaget LM Ericsson | 240.31B |
| H & M Hennes & Mauritz AB | 231.26B |
| Atlas Copco AB | 171.55B |
| ASSA ABLOY AB | 153.68B |
| Investor AB | 133.31B |
| Sandvik AB | 120.37B |
| Skandinaviska Enskilda Banken AB | 76.49B |